Inspire Medical Systems Other Long-Term Assets 2017-2025 | INSP

Inspire Medical Systems other long-term assets from 2017 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Inspire Medical Systems Annual Other Long-Term Assets
(Millions of US $)
2024 $11
2023 $11
2022 $11
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
Inspire Medical Systems Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $12
2024-12-31 $11
2024-09-30 $11
2024-06-30 $11
2024-03-31 $11
2023-12-31 $11
2023-09-30 $12
2023-06-30 $12
2023-03-31 $11
2022-12-31 $11
2022-09-30 $11
2022-06-30 $10
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.305B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.320B 52.93
Hims & Hers Health (HIMS) United States $11.979B 124.46
Tempus AI (TEM) United States $10.204B 0.00
IRhythm Technologies (IRTC) United States $4.547B 0.00
Privia Health (PRVA) United States $2.816B 192.50
Enovis (ENOV) United States $1.849B 10.31
Clover Health Investments (CLOV) United States $1.669B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Phreesia (PHR) United States $1.447B 0.00
Omnicell (OMCL) United States $1.351B 23.83
Azenta (AZTA) United States $1.283B 59.64
10x Genomics (TXG) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.625B 0.00
Butterfly Network (BFLY) United States $0.529B 0.00
Claritev (CTEV) United States $0.479B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.462B 138.00
Standard BioTools (LAB) United States $0.363B 0.00
TruBridge (TBRG) United States $0.356B 789.67
Outset Medical (OM) United States $0.327B 0.00
Nyxoah SA (NYXH) Belgium $0.283B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.097B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00